Live Vaccines Market 2027 by Type, Route of Administration, Application, Patient Type | The Insight Partners

Live Vaccines Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type ( Bacterial, Viral ); Route of Administration ( Oral, Intravenous, Subcutaneous, Others ); Application ( Mumps, Rubella, Varicella, Yellow Fever, Rotavirus, BCG, Others ); Patient Type ( Adult, Pediatric )

Report Code: TIPRE00009281 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Live attenuated vaccines are prepared from living micro-organisms such as viruses and bacteria which have been weakened under controlled laboratory environment. These vaccines will replicate in a vaccinated patient and harvest an immune response which will prevent the occurring of disease.

MARKET DYNAMICS

Increasing awareness of benefits offered by live vaccines coupled with supportive government programs are projected to drive the growth of live vaccines market by 2027. However, risk associated with the adverse effects are expected to hamper the growth of the market.

MARKET SCOPE

The "Live Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Live Vaccines Market with detailed market segmentation by type, route of administration, application, patient type and geography. The Live Vaccines Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Live Vaccines Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Live Vaccines Market is segmented on the basis by type, route of administration, application, and patient type. Based on type, the market is segmented into viral and bacterial. Based on route of administration, the market is segmented into oral, intravenous, subcutaneous, and others. Based on application, the market is segmented into mumps, rubella, varicella, yellow fever, rotavirus, bcg, and others. Based on patient type, the market is segmented into adult and pediatrics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Live Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Live Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Live Vaccines Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Live Vaccines Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Live Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Live Vaccines Market are anticipated to lucrative growth opportunities in the future with the rising demand for Live Vaccines Market in the global market. Below mentioned is the list of few companies engaged in the Live Vaccines Market.

The report also includes the profiles of key Live Vaccines Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Astellas Pharma Inc.
- Emergent BioSolutions
- Pfizer Inc.
- Merck KGaA
- AstraZeneca plc
- Bharat Biotech
- Serum Institute of India Pvt. Ltd.
- Sun Pharmaceutical Industries Limited
- Cipla Limited
- GlaxoSmithKline plc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Live Vaccines Market - By Type
1.3.2 Live Vaccines Market - By Route of Administration
1.3.3 Live Vaccines Market - By Application
1.3.4 Live Vaccines Market - By Patient Type
1.3.5 Live Vaccines Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVE VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVE VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LIVE VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVE VACCINES - GLOBAL MARKET OVERVIEW
6.2. LIVE VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LIVE VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BACTERIAL
7.3.1. Overview
7.3.2. Bacterial Market Forecast and Analysis
7.4. VIRAL
7.4.1. Overview
7.4.2. Viral Market Forecast and Analysis
8. LIVE VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. SUBCUTANEOUS
8.5.1. Overview
8.5.2. Subcutaneous Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. LIVE VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MUMPS
9.3.1. Overview
9.3.2. Mumps Market Forecast and Analysis
9.4. RUBELLA
9.4.1. Overview
9.4.2. Rubella Market Forecast and Analysis
9.5. VARICELLA
9.5.1. Overview
9.5.2. Varicella Market Forecast and Analysis
9.6. YELLOW FEVER
9.6.1. Overview
9.6.2. Yellow Fever Market Forecast and Analysis
9.7. ROTAVIRUS
9.7.1. Overview
9.7.2. Rotavirus Market Forecast and Analysis
9.8. BCG
9.8.1. Overview
9.8.2. BCG Market Forecast and Analysis
9.9. OTHERS
9.9.1. Overview
9.9.2. Others Market Forecast and Analysis
10. LIVE VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - PATIENT TYPE
10.1. OVERVIEW
10.2. PATIENT TYPE MARKET FORECASTS AND ANALYSIS
10.3. ADULT
10.3.1. Overview
10.3.2. Adult Market Forecast and Analysis
10.4. PEDIATRIC
10.4.1. Overview
10.4.2. Pediatric Market Forecast and Analysis
11. LIVE VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Live Vaccines Market Overview
11.1.2 North America Live Vaccines Market Forecasts and Analysis
11.1.3 North America Live Vaccines Market Forecasts and Analysis - By Type
11.1.4 North America Live Vaccines Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Live Vaccines Market Forecasts and Analysis - By Application
11.1.6 North America Live Vaccines Market Forecasts and Analysis - By Patient Type
11.1.7 North America Live Vaccines Market Forecasts and Analysis - By Countries
11.1.7.1 United States Live Vaccines Market
11.1.7.1.1 United States Live Vaccines Market by Type
11.1.7.1.2 United States Live Vaccines Market by Route of Administration
11.1.7.1.3 United States Live Vaccines Market by Application
11.1.7.1.4 United States Live Vaccines Market by Patient Type
11.1.7.2 Canada Live Vaccines Market
11.1.7.2.1 Canada Live Vaccines Market by Type
11.1.7.2.2 Canada Live Vaccines Market by Route of Administration
11.1.7.2.3 Canada Live Vaccines Market by Application
11.1.7.2.4 Canada Live Vaccines Market by Patient Type
11.1.7.3 Mexico Live Vaccines Market
11.1.7.3.1 Mexico Live Vaccines Market by Type
11.1.7.3.2 Mexico Live Vaccines Market by Route of Administration
11.1.7.3.3 Mexico Live Vaccines Market by Application
11.1.7.3.4 Mexico Live Vaccines Market by Patient Type
11.2. EUROPE
11.2.1 Europe Live Vaccines Market Overview
11.2.2 Europe Live Vaccines Market Forecasts and Analysis
11.2.3 Europe Live Vaccines Market Forecasts and Analysis - By Type
11.2.4 Europe Live Vaccines Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Live Vaccines Market Forecasts and Analysis - By Application
11.2.6 Europe Live Vaccines Market Forecasts and Analysis - By Patient Type
11.2.7 Europe Live Vaccines Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Live Vaccines Market
11.2.7.1.1 Germany Live Vaccines Market by Type
11.2.7.1.2 Germany Live Vaccines Market by Route of Administration
11.2.7.1.3 Germany Live Vaccines Market by Application
11.2.7.1.4 Germany Live Vaccines Market by Patient Type
11.2.7.2 France Live Vaccines Market
11.2.7.2.1 France Live Vaccines Market by Type
11.2.7.2.2 France Live Vaccines Market by Route of Administration
11.2.7.2.3 France Live Vaccines Market by Application
11.2.7.2.4 France Live Vaccines Market by Patient Type
11.2.7.3 Italy Live Vaccines Market
11.2.7.3.1 Italy Live Vaccines Market by Type
11.2.7.3.2 Italy Live Vaccines Market by Route of Administration
11.2.7.3.3 Italy Live Vaccines Market by Application
11.2.7.3.4 Italy Live Vaccines Market by Patient Type
11.2.7.4 Spain Live Vaccines Market
11.2.7.4.1 Spain Live Vaccines Market by Type
11.2.7.4.2 Spain Live Vaccines Market by Route of Administration
11.2.7.4.3 Spain Live Vaccines Market by Application
11.2.7.4.4 Spain Live Vaccines Market by Patient Type
11.2.7.5 United Kingdom Live Vaccines Market
11.2.7.5.1 United Kingdom Live Vaccines Market by Type
11.2.7.5.2 United Kingdom Live Vaccines Market by Route of Administration
11.2.7.5.3 United Kingdom Live Vaccines Market by Application
11.2.7.5.4 United Kingdom Live Vaccines Market by Patient Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Live Vaccines Market Overview
11.3.2 Asia-Pacific Live Vaccines Market Forecasts and Analysis
11.3.3 Asia-Pacific Live Vaccines Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Live Vaccines Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Live Vaccines Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Live Vaccines Market Forecasts and Analysis - By Patient Type
11.3.7 Asia-Pacific Live Vaccines Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Live Vaccines Market
11.3.7.1.1 Australia Live Vaccines Market by Type
11.3.7.1.2 Australia Live Vaccines Market by Route of Administration
11.3.7.1.3 Australia Live Vaccines Market by Application
11.3.7.1.4 Australia Live Vaccines Market by Patient Type
11.3.7.2 China Live Vaccines Market
11.3.7.2.1 China Live Vaccines Market by Type
11.3.7.2.2 China Live Vaccines Market by Route of Administration
11.3.7.2.3 China Live Vaccines Market by Application
11.3.7.2.4 China Live Vaccines Market by Patient Type
11.3.7.3 India Live Vaccines Market
11.3.7.3.1 India Live Vaccines Market by Type
11.3.7.3.2 India Live Vaccines Market by Route of Administration
11.3.7.3.3 India Live Vaccines Market by Application
11.3.7.3.4 India Live Vaccines Market by Patient Type
11.3.7.4 Japan Live Vaccines Market
11.3.7.4.1 Japan Live Vaccines Market by Type
11.3.7.4.2 Japan Live Vaccines Market by Route of Administration
11.3.7.4.3 Japan Live Vaccines Market by Application
11.3.7.4.4 Japan Live Vaccines Market by Patient Type
11.3.7.5 South Korea Live Vaccines Market
11.3.7.5.1 South Korea Live Vaccines Market by Type
11.3.7.5.2 South Korea Live Vaccines Market by Route of Administration
11.3.7.5.3 South Korea Live Vaccines Market by Application
11.3.7.5.4 South Korea Live Vaccines Market by Patient Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Live Vaccines Market Overview
11.4.2 Middle East and Africa Live Vaccines Market Forecasts and Analysis
11.4.3 Middle East and Africa Live Vaccines Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Live Vaccines Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Live Vaccines Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Live Vaccines Market Forecasts and Analysis - By Patient Type
11.4.7 Middle East and Africa Live Vaccines Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Live Vaccines Market
11.4.7.1.1 South Africa Live Vaccines Market by Type
11.4.7.1.2 South Africa Live Vaccines Market by Route of Administration
11.4.7.1.3 South Africa Live Vaccines Market by Application
11.4.7.1.4 South Africa Live Vaccines Market by Patient Type
11.4.7.2 Saudi Arabia Live Vaccines Market
11.4.7.2.1 Saudi Arabia Live Vaccines Market by Type
11.4.7.2.2 Saudi Arabia Live Vaccines Market by Route of Administration
11.4.7.2.3 Saudi Arabia Live Vaccines Market by Application
11.4.7.2.4 Saudi Arabia Live Vaccines Market by Patient Type
11.4.7.3 U.A.E Live Vaccines Market
11.4.7.3.1 U.A.E Live Vaccines Market by Type
11.4.7.3.2 U.A.E Live Vaccines Market by Route of Administration
11.4.7.3.3 U.A.E Live Vaccines Market by Application
11.4.7.3.4 U.A.E Live Vaccines Market by Patient Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Live Vaccines Market Overview
11.5.2 South and Central America Live Vaccines Market Forecasts and Analysis
11.5.3 South and Central America Live Vaccines Market Forecasts and Analysis - By Type
11.5.4 South and Central America Live Vaccines Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Live Vaccines Market Forecasts and Analysis - By Application
11.5.6 South and Central America Live Vaccines Market Forecasts and Analysis - By Patient Type
11.5.7 South and Central America Live Vaccines Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Live Vaccines Market
11.5.7.1.1 Brazil Live Vaccines Market by Type
11.5.7.1.2 Brazil Live Vaccines Market by Route of Administration
11.5.7.1.3 Brazil Live Vaccines Market by Application
11.5.7.1.4 Brazil Live Vaccines Market by Patient Type
11.5.7.2 Argentina Live Vaccines Market
11.5.7.2.1 Argentina Live Vaccines Market by Type
11.5.7.2.2 Argentina Live Vaccines Market by Route of Administration
11.5.7.2.3 Argentina Live Vaccines Market by Application
11.5.7.2.4 Argentina Live Vaccines Market by Patient Type
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LIVE VACCINES MARKET, KEY COMPANY PROFILES
13.1. ASTELLAS PHARMA INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. EMERGENT BIOSOLUTIONS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK KGAA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ASTRAZENECA PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BHARAT BIOTECH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SERUM INSTITUTE OF INDIA PVT. LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SUN PHARMACEUTICAL INDUSTRIES LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CIPLA LIMITED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GLAXOSMITHKLINE PLC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BHARAT BIOTECH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SERUM INSTITUTE OF INDIA PVT. LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SUN PHARMACEUTICAL INDUSTRIES LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CIPLA LIMITED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GLAXOSMITHKLINE PLC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERM
The List of Companies

1. Astellas Pharma Inc.
2. Emergent BioSolutions
3. Pfizer Inc.
4. Merck KGaA
5. AstraZeneca plc
6. Bharat Biotech
7. Serum Institute of India Pvt. Ltd.
8. Sun Pharmaceutical Industries Limited
9. Cipla Limited
10. GlaxoSmithKline plc.
TIPRE00009281
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking